0001673503-21-000001.txt : 20211112 0001673503-21-000001.hdr.sgml : 20211112 20211112164130 ACCESSION NUMBER: 0001673503-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 EFFECTIVENESS DATE: 20211112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gila Therapeutics, Inc. CENTRAL INDEX KEY: 0001673503 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-389531 FILM NUMBER: 211404307 BUSINESS ADDRESS: STREET 1: 1712 HUMBOLT AVENUE SOUTH CITY: MINNEAPOLIS STATE: MN ZIP: 55403 BUSINESS PHONE: 612-805-9054 MAIL ADDRESS: STREET 1: 1712 HUMBOLT AVENUE SOUTH CITY: MINNEAPOLIS STATE: MN ZIP: 55403 D/A 1 primary_doc.xml X0708 D/A LIVE 0001673503 Gila Therapeutics, Inc. 198Tremont Street Boston MA MASSACHUSETTS 02216 612-805-9054 DELAWARE None None Corporation true Scott Schorer 198Tremont Street Boston MA MASSACHUSETTS 02216 Executive Officer Director Jon Freeman 198Tremont Street Boston MA MASSACHUSETTS 02216 Executive Officer Thomas Vasicek 198Tremont Street Boston MA MASSACHUSETTS 02216 Executive Officer Christopher de Souza 198Tremont Street Boston MA MASSACHUSETTS 02216 Director Richard Horan 198Tremont Street Boston MA MASSACHUSETTS 02216 Director Biotechnology Decline to Disclose 06b true 0001437749-21-002956 2021-01-29 false true true false 0 1250000 1250000 0 false 28 0 0 0 false Gila Therapeutics, Inc. Scott Schorer Scott Schorer Chief Executive Officer 2021-11-12